drugset / Trial / NCT06703710
To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers
RandomizedSequentialDouble-blindOther
Summary
This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.
Timeline
- Start
- 2025-01-06
- Primary completion
- 2025-11
- Completion
- 2026-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JW2286 | Unknown | — | Oral |
Indications
No indication recorded.